Elizabeth Shpall, MD
University of Texas MD Anderson Cancer Center
Elizabeth Shpall, MD, is Medical Director of the Cell Therapy Laboratory, Director of the Cord Blood Bank and Deputy Chair of the Department of Stem Cell Transplantation and Cellular Therapy at The University of Texas M.D. Anderson Cancer Center. Dr. Shpall has more than 25 years of experience performing stem cell transplants and translating stem cell graft manipulations from the laboratory to the clinic. She has had continuous RO1 funding from the National Cancer Institute for the past 18 years, and lead a recently funded PO1 on improving cord blood transplantation focusing recently on the ex vivo expansion of umbilical cord blood in allogeneic mesenchymal stem cell co-cultures. She received a CPRIT High Risk/High Reward grant for the development of cord blood-derived Natural Killer (NK) cells, and a CLL Alliance grant to evaluate cord blood-NK cells in CLL patients. Dr. Shpall is the immediate past president of the American Society of Blood and Marrow Transplantation (ASBMT) and vice president of Netcord. Having served as the founding president for the Foundation of Accreditation of Cellular Therapy and as past president of ASBMT, Dr. Shpall has successfully mentored residents, post-doctoral fellows, and junior faculty over the last 25 years and has ensured that mentees are able to establish their own clinical and/or research niches.
Mary Gospodarowicz, MD, FRCR, FRCPC
University of Toronto, Princess Margaret Cancer Centre, and Cancer Care Ontario
Mary K. Gospodarowicz, MD, is the medical director at Princess Margaret Cancer Centre and regional vice president of Cancer Care Ontario. She recently served as president for the Union for International Cancer Control (UICC). Dr. Gospodarowicz’s research interests focus on the role of radiation therapy in lymphomas, prostate cancer, bladder cancer, and testis cancer clinical trials. Her numerous mentees describe her as a committed, compassionate, strong advocate for female professionals who leads by example.
Mary Gospodarowicz is Professor of Radiation Oncology at the University of Toronto, the Medical Director of the Princess Margaret Cancer Centre at the University Health Network, and the Regional Vice President of Cancer Care Ontario. She is past Chair of Radiation Oncology at the University of Toronto. She holds specialty certifications in internal medicine, radiation oncology, and medical oncology and her clinical practice involves lymphomas and genitourinary cancers. Her research focused on clinical trials evaluating radiation therapy, image-guided precision radiotherapy, and cancer survivorship. Her current interests include global cancer control, global access to radiotherapy, and quality cancer care. Her numerous mentees describe her as a committed, compassionate, strong advocate for female professionals who leads by example.
Professor Gospodarowicz is Past-President of the Union for International Cancer Control (UICC). She proudly participates in the work of the Global Task Force on Cancer Care and Control of Harvard Global Equity Initiative and the HGEI-Lancet Commission on Global Access to Pain Control & Palliative Care. Under the auspices of UICC and Lancet Oncology, the Global Task Force on Radiotherapy produced a seminal report on ‘Expanding the global access to radiotherapy” that provided evidence for the demand, efficacy, and cost effectiveness of radiotherapy.
Sarah S. Donaldson, MD, FASCO
An esteemed faculty member since 1973 and the unofficial "heart and soul of radiation oncology" at Stanford University School of Medicine, Dr. Donaldson is perhaps most widely known for her decades-long research and contributions related to improving quality of treatment and of life for children with cancer. Yet, it is her unwavering dedication to mentorship that distinguishes her as the utmost role model to young women oncologists today. Dr. Donaldson is the Catharine and Howard Avery Professor in the Department of Radiation Oncology at Stanford University School of Medicine, as well as the Associate Director of the residency program at Stanford's Department of Radiation Oncology and Chief of the Radiation Oncology service at the Packard Children's Hospital in Stanford, California.
Dr. Donaldson is a woman of truly remarkable achievement and has consistently paved the way for women in oncology for nearly half a century. She attended Dartmouth Medical School as one of only six women in a class of 48 students. She was the first female president of the American Board of Radiology and of the American Society for Therapeutic Radiology and Oncology (ASTRO). She was the first female radiation oncologist to serve as president of the Radiological Society of North America. She has served on the ASCO and Conquer Cancer Boards of Directors, and is a member of the National Academy of Medicine/Institute of Medicine. Still, current and former colleagues name her role as mentor among the most defining of her illustrious career.